Company / Cost of Revenue
Sigyn Therapeutics, Inc. Cost of Revenue History
FY2015-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$35.7K
FY2019
5-year range
$9.7K / $35.7K
FY2015-FY2019
Trend
+267.2%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cost of Revenue changed +267% YoY in FY2019, a notable deviation from the 2-year average annual change of +133%.
Based on SEC 10-K filings.
$35,665 in FY2019.
Increased from $9,930 to $35,665 over the past 4 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, cost of revenue increased 267.2% year-over-year.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $35.7K | +267.2% |
| FY2018 | $9.7K | -2.2% |
| FY2015 | $9.9K | - |
As of FY2019 · SEC 10-K · Updated Jun 29, 2026